DOCETAXEL RETREATMENT IN DOCETAXEL-PRETREATED CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Di Lorenzo, Giuseppe [1 ]
Palmieri, Giovannella [1 ]
Buonerba, Carlo [1 ]
Marinelli, Alfredo [1 ]
De Placido, Sabino [1 ]
Altieri, Vincenzo [2 ]
Ferro, Matteo [2 ]
Mariano, Marsicano [2 ]
Vittorino, Montanaro [2 ]
Luigi, Castaldo [2 ]
Antonio, Tesone [2 ]
Modestino, Tronino [2 ]
机构：
[1] Univ Naples Federico 2, Dipartimento Endocrinol & Oncol Clin & Molecolare, I-80100 Naples, Italy
[2] Univ Naples Federico 2, Inst Urol, Dipartimento Scienze Ostetr Ginecolog Urolog & Me, I-80100 Naples, Italy
来源：
ANTICANCER RESEARCH | 2010年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
273
引用
收藏
页码：1533 / 1533
页数：1
相关论文
共 50 条
  • [31] Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
    Akiyuki Yamamoto
    Masashi Kato
    Hirotaka Matsui
    Ryo Ishida
    Tohru Kimura
    Yasuhito Funahashi
    Naoto Sassa
    Yoshihisa Matsukawa
    Osamu Kamihira
    Ryohei Hattori
    Momokazu Gotoh
    Toyonori Tsuzuki
    International Journal of Clinical Oncology, 2018, 23 : 584 - 590
  • [32] Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
    Yamamoto, Akiyuki
    Kato, Masashi
    Matsui, Hirotaka
    Ishida, Ryo
    Kimura, Tohru
    Funahashi, Yasuhito
    Sassa, Naoto
    Matsukawa, Yoshihisa
    Kamihira, Osamu
    Hattori, Ryohei
    Gotoh, Momokazu
    Tsuzuki, Toyonori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 584 - 590
  • [33] Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC)
    Reuter, C. W.
    Morgan, M. A.
    Gruenwald, V.
    Fenner, M.
    Ivanyi, P.
    Ganser, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [34] CARBOPLATIN PLUS WEEKLY DOCETAXEL AS SALVAGE CHEMOTHERAPY IN DOCETAXEL-RESISTANT AND CASTRATION-RESISTANT PROSTATE CANCER (DRPC)
    Reuter, C.
    Morgan, M. A.
    Fenner, M.
    Ivanyi, P.
    Ganser, A.
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 301 - 301
  • [35] Docetaxel-based combination therapy for castration-resistant prostate cancer
    Galsky, M. D.
    Vogelzang, N. J.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2135 - 2144
  • [36] What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?
    Steineck, Gunnar
    Glimelius, Bengt
    ACTA ONCOLOGICA, 2013, 52 (08) : 1589 - 1592
  • [37] Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
    C Wilson
    P Scullin
    J Worthington
    A Seaton
    P Maxwell
    D O'Rourke
    P G Johnston
    S R McKeown
    R H Wilson
    J M O'Sullivan
    D J J Waugh
    British Journal of Cancer, 2008, 99 : 2054 - 2064
  • [38] Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
    Kreis, Kristine
    Horenkamp-Sonntag, Dirk
    Schneider, Udo
    Zeidler, Jan
    Glaeske, Gerd
    Weissbach, Lothar
    BJU INTERNATIONAL, 2022, 129 (04) : 470 - 479
  • [39] Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience
    Beatrice, Detti
    Davide, Franceschini
    Calogero, Saieva
    Lucia, Di Brina
    Mohammed, Baki
    Icro, Meattini
    Vanessa, Di Cataldo
    Eleonora, Monteleone Pasquetti
    Ilaria, Furfaro
    Anna, Mancuso
    Gabriele, Simontacchi
    Lorenzo, Livi
    CANCER INVESTIGATION, 2014, 32 (09) : 445 - 450
  • [40] Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer
    Heck, Matthias M.
    Thalgott, Mark
    Retz, Margitta
    Wolf, Petra
    Maurer, Tobias
    Nawroth, Roman
    Hatzichristodoulou, Georgios
    Gschwend, Jurgen E.
    Kuebler, Huebert
    BJU INTERNATIONAL, 2012, 110 (11B) : E635 - E640
12345